GREGORY D LORD MD NPI 1639162290

NPI Details

Gregory D Lord, MD is a general practice in Leesville, LA with 45 years of experience. The provider is a physician who specializes in the general practice of diagnosing, treating, and managing patients with a variety of illnesses and conditions. Source: National Uniform Claim Committee Gregory D Lord, MD NPI is 1639162290. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE IN SHREVEPORT
Graduation Year:1981

The provider's business location address is:

301 W FERTITTA BLVD STE 1
LEESVILLE, LA
ZIP 71446-665
Phone: (337) 238-0167
Fax: (337) 238-0574

The NPI 1639162290 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
• X-ray of chest, 2 views (HCPCS:71046)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Vitamin d-3 level (HCPCS:82306)
• Hemoglobin a1c level (HCPCS:83036)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Follow-up nursing facility visit per day, typically 15 minutes (HCPCS:99308)
• Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free (HCPCS:90674)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• Follow-up nursing facility visit per day, typically 15 minutes (HCPCS:99308)
• Urine microalbumin (protein) level (HCPCS:82043)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) (HCPCS:87811)
• Follow-up nursing facility visit per day, typically 25 minutes (HCPCS:99309)
• Follow-up nursing facility visit per day, typically 25 minutes (HCPCS:99309)
• Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a (HCPCS:G0179)
• Blood test, clotting time (HCPCS:85610)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg (HCPCS:J0702)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Initial nursing facility visit per day, typically 45 minutes (HCPCS:99306)
• Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and (HCPCS:G0180)
• X-ray of lower and sacral spine, minimum of 4 views (HCPCS:72110)
• Stool analysis for blood to screen for colon tumors (HCPCS:82270)
• X-ray of knee, 4 or more views (HCPCS:73564)
• X-ray of shoulder, minimum of 2 views (HCPCS:73030)
• Uric acid level, blood (HCPCS:84550)
• X-ray of abdomen, 1 view (HCPCS:74018)
• X-ray of hip, 2-3 views (HCPCS:73502)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Removal of impacted ear wax (HCPCS:69210)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• X-ray of upper spine, 4-5 views (HCPCS:72050)
• Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)
• X-ray of ribs on side of body, minimum of 3 views (HCPCS:71101)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 8/29/2005 and was last updated on 7/8/2007.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.